SoFi Small Business Lending Drives SOFI’s +2.7% Surge
Can SoFi Small Business Lending turn a fintech lender into Wall Street’s next serious banking challenger? Maik Kemper Editor in Chief SoFi Small Business Lending isn’t just about…
Charles Schwab 200-Day Average Breakout as SCHW Jumps 3.7%
Is the Charles Schwab 200-Day Average breakout the start of a bigger SCHW move, or just another short-lived technical tease? Maik Kemper Editor in Chief SCHW’s move above…
Microsoft AI Strategy +3.9% as Sovereign AI Push Accelerates
Can Microsoft AI Strategy turn sovereign cloud demand into a lasting edge as spending rises and rivals close in? Maik Kemper Editor in Chief Nordrhein-Westfalen ist für Microsoft…
Salesforce Upgrade +5% as Guggenheim Rejects AI Panic
Is this Salesforce Upgrade the start of a real rerating, or just a brief rebound after Wall Street priced in too much AI fear? Maik Kemper Editor in…
AMD Forecast -5.2%: Warning as Wall Street Lifts Targets
Is AMD’s 5% drop a warning sign for the AI trade, or just a pause before analysts’ higher targets take over? Maik Kemper Editor in Chief The server…
Solana Prediction Market: SOL Surges as World Goes Live
Can a Solana Prediction Market inside Phantom turn onchain betting into the next major catalyst for SOL adoption? Maik Kemper Editor in Chief Prediction markets are one of…
TSMC Forecast -6.3%: Why Target Hikes Failed to Lift Shares
Why is the TSMC Forecast getting stronger just as the stock suffers a sharp sell-off? Maik Kemper Editor in Chief TSMC remains the irreplaceable engine of AI hardware…
Caterpillar Short Bet -7% as Valuation Fears Deepen
Is Caterpillar’s AI-powered rally cracking as short sellers target stretched valuation and weakening margins? Maik Kemper Editor in Chief Caterpillar’s valuation no longer reflects industrial fundamentals — it…
Robinhood Crypto Expansion Sends HOOD Soaring 8.1%
Can Robinhood Crypto Expansion turn HOOD into more than a trading app story and into a real blockchain infrastructure winner? Maik Kemper Editor in Chief Decentralized finance unlocks…
Hims & Hers Health Forecast Jumps 8% on Analyst Upgrades
Can analyst optimism outweigh FDA peptide uncertainty in the Hims & Hers Health Forecast after an 8% stock surge? Maik Kemper Editor in Chief The FDA’s recommendation appears…